Uveitis Forecast in 10 Major Markets 2015-2025

Uveitis is a general term associated with a group of inflammatory conditions that produce swelling and causes injury to the eye. The cause of Uveitis varies greatly in respect to the geography. The main causes include that of infectious agents or linked to systemic autoimmune diseases. In this report the infectious and immune causes of Uveitis are examined. This report provides the current prevalent population for Uveitis across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, China and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors and prevention, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Uveitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Uveitis include:

• Autoimmune diseases (systemic)
• Ocular hypertension
• Macular oedema
• Reduction in visual acuity
• Presence of epiretinal membranes
• Diabetes mellitus
• Tuberculosis

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global Uveitis’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Uveitis and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Useful in the identification and trend of the prevalence numbers for the different causative agents of Uveitis.
• Provide a level of understanding on the impact from specific co-morbid conditions on Uveitis’s prevalent population.
• Identify sub-populations within Uveitis which require treatment.
• Gain an understanding of the specific markets that have the largest number of Uveitis patients.